Related Experiment Video
Updated: May 5, 2026

04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
11.5K
Wearable Movement Exploration Device with Machine Learning Algorithm for Screening and Tracking Diabetic Neuropathy-A
Goran Radunovic1,2, Zoran Velickovic1, Slavica Pavlov-Dolijanovic1,2
1Institute of Rheumatology, 11000 Belgrade, Serbia.
Biosensors
|April 26, 2024
Summary
The Moveo device accurately detects diabetic neuropathy using machine learning, offering a user-friendly, less painful alternative to traditional methods for home use.
Area of Science:
- Biomedical Engineering
- Medical Technology
- Machine Learning in Healthcare
Background:
- Diabetic neuropathy is a common diabetes complication.
- Early detection and tracking are crucial for management.
- Novel devices are needed to improve accessibility and patient experience.
Purpose of the Study:
- To evaluate the Moveo device for detecting and tracking diabetic neuropathy.
- To assess the accuracy and usability of a machine learning-based system.
- To compare the Moveo device with traditional electrodiagnostic examinations.
Main Methods:
- A pilot study involving 23 participants (11 with diabetes, 11 with suspected radiculopathy, 4 healthy).
- The Moveo device uses sensors and a mobile app to collect movement data, processed by a cloud-based machine learning algorithm.
- Participants underwent both Moveo and electrodiagnostic examinations; user experience questionnaires were administered.
Main Results:
- The Moveo device achieved 82.1% overall accuracy, with 78% sensitivity and 87% specificity.
- A high linear correlation (up to 0.722) was found between Moveo and electrodiagnostic examination (EDx) features.
- Most participants preferred the Moveo device due to its less painful nature.
Conclusions:
- The Moveo device is an accurate and user-friendly tool for detecting diabetic neuropathy.
- Its suitability for home environments shows significant potential for future clinical application.
- Moveo offers a promising, accessible alternative for managing diabetic neuropathy.

